Wednesday 26 October 2016 - Room 109/110, Level 1, Melbourne Convention Centre
8.30am - 4.30pm Registration desk open
9.00 - 9.05am

Welcome and Official Opening

Glenn Cross, Chief Executive Officer, AusBiotech

9.05 - 9.10am

Welcome Address
The Hon Philip Dalidakis, Minister for Small Business, Innovation & Trade

9.10 - 9.30am

Keynote: Biotech investing in a global market: Leveraging US / Australian Opportunities

Warren Dunnavant, Director - Investment Banking, ROTH Capital Partners, LLC

9.30 - 10.05am

Panel: International Investment Update

Moderator: Hershel Berry, Managing Partner, Blueprint Life Science Group

 

Panellists:

Dr Stuart Collinson, Director, Forward Ventures

Dr Ron Laufer, Senior Managing Director, MedImmune Ventures
Gordon Waldron, President, Sequoia Business Solutions SAS, France

10.05 - 10.30am

Company spotlight presentations

John Martin, CEO, Regeneus

Dr James Garner, CEO, Novogen

Dr Michelle Fraser, Managing Director & CEO, Reproductive Health Science

10.30 - 11.00am Morning Tea and networking with exhibitors
11.00 - 11.45am

Panel: Big Pharma

Moderator: Lorraine Chiroiu, Deputy CEO, AusBiotech

 

Panellists:
Dr Jeanne Bolger, Vice President Venture Investments, Johnson & Johnson Innovation 

Dr Chris Carol Bremer, Senior VP/Head, Commercial Strategy & Market Insights Europe & Australia, Grunenthal Europe
Dr Yuan-Hua Ding, External R&D Innovation - Asia Pacific, Pfizer
Dr Reginald Seeto, Head of Partnering and Strategy, MedImmune

Dr Will Shen, Director, Mergers & Acquisitions, Bristol-Myers Squibb

11.45am - 12.25pm

Company spotlight presentations

Dr Paul MacLeman, Managing Director & CEO, IDT Australia

Peter Culpepper, Interim CEO, Provectus Biopharmaceuticals

Dr Ross Murdoch, CEO & Managing Director, Phosphagenics

Dr Karen Duggan, CEO, Vectus Biosystems

12.25 - 1.30pm Lunch and networking with exhibitors
1.30 - 2.00pm

Company spotlight presentations

Dr Jeremy Chrisp, CEO, EpiAxis

Sam Cobb, CEO, AdAlta Ltd

Dr David Fisher, Executive Director, GI Therapies

2.00 - 3.00pm

Panel: Alternative Funding

Moderator: Dr Amanda Gillon, Investment Manager, Bioscience Managers

 

Panellists:

Ross Curtin, CEO, WealthSpring International Group

Ram May-Ron, Managing Partner, FreeMind Group

 3.00 - 3.30pm

Afternoon tea and networking with exhibitors

 3.30 - 4.00pm

Company Spotlight Presentations

Peter Molloy, CEO, Race Oncology
Paul Anderson, Managing Director, Orthocell

Garth Sutherland, Group CEO, Adherium

 4.00 - 4.40pm

Panel: Australian Stockbrokers

Moderator: Dr Amanda Gillon, Investment Manager, Bioscience Managers

 

Panellists:

Joanna Hill, Financial Advisor, Baillieu Holst

Sam Street, Director - Corporate Finance, Morgans Financial

Anton Whitehead, Director - Equity Capital Markets, Bell Potter

4.40 - 4.45pm

Close of conference day 1

4.45 - 6.00pm

International BioFest Networking Reception

Held in conjunction with AusBiotech 2016 and the International Biotechnology Symposium

Melbourne Convention Centre, Level 2, Foyer

 

Thursday 27 October 2016 - Room 109/110, Level 1, Melbourne Convention Centre
8.30am - 3.30pm Registration desk open
9:00 - 9:05am

Conference Chairman opening remarks and recap of day one

Mark Pachacz, Analyst, Bioshares

9.05 - 9.25am

Keynote: Investing in biotech - A global perspective
Dr Bianca Ogden, Portfolio Manager, Platinum Asset Management Ltd

9.25 - 10.00am

Panel: Life science investment in Asia

Moderator: Mark Pachacz, Analyst, Bioshares

Speakers:
Donald Xu, Managing Director, Lynx Financial

CT Johnson, General Manager, Basis Point

Rob Scott, Director, China BlueSky Partners

10.00 - 10.30am

Company spotlight presentations
Dr Michelle Miller, CEO & Managing Director, Biotron Ltd

Elaine Darby, Managing Director, AusCann Group Holdings

Dr Deborah Rathjen, CEO & Managing Director, Bionomics

10.30 - 10.40am

Keynote: ASX update - New listings and admissions requirements

Rory Cunningham, Manager - Listings Business Development, ASX Ltd

10.40 - 11.10am

Morning tea and networking with exhibitors

11.10 - 11.30am

Keynote: Texas Medical Centre and Bio Bridge to Australia

Bill McKeon, Executive Vice President, Chief Strategy and Operating Officer, Texas Medical Centre

11.30 - 12.00pm

Panel: Investing in digital health

Moderator: Bronwyn Le Grice, Principal, Fidere Group

Speakers:

Andrew Ronchi, CEO, DorsaVi

Sam Holt, CEO, GP2U

12.00 - 12.40pm

Company Spotlight Presentations

Arie Nudel, Managing Director, Omniblend Innovation

Ross Barrow, CEO & Director, Paranta Biosciences
Dr Richard Lipscombe, Managing Director, Proteomics International Labs

Dr Andrew Bray, CEO, Elk OrthoBiologics

12.40 - 2.00pm

Lunch and networking with exhibitors

Supported by Bristol-Myers Squibb

 2.00 - 2.20pm

Keynote: Icing a globally competitive biotech industry: The Canadian Experience

Andrew Casey, President & CEO, BIOTECanada

2.20 - 3.10pm

Company spotlight presentations

Brent Barnes, CEO & Managing Director, LBT Innovations

Julie Phillips, Managing Director, Opal Biosciences
Ben Foskett, Chair, Nanjing Biopoint

2.50 - 3.30pm

Panel: New model for medical device investing

Moderator: Paul Carboon, Business Development Manager, Hydrix

Speakers:
Richard Hannebery, Lodge Partners

Peter Rowland, CEO, Micro-X Pty Ltd

3:30 - 3:45pm

Company spotlight presentations
Peter Saunders, CEO & Co-Founder, Health Delivered

Dr James Freeman, CEO, SkinView

Philip Crealy, Director - Translational Research, Petri Exchange

3:45 - 4:00pm Chairmans closing remarks and end of conference